Historical Development and Strategic Growth
LSB MedTech Holding Group Ltd, originally founded in the Netherlands, has since relocated its headquarters to the United Arab Emirates while maintaining multiple subsidiaries across Europe.

Until mid-2018, LSB MedTech, together with Maastricht University, was a co-owner and investor in Vitak Group Ltd. Vitak Group was the world’s largest MGP CRO laboratory. Within this organization, a specialized medical technology division was established, focusing on innovations in vascular elasticity monitoring and anticoagulants. Additionally, the pharmaceutical division specialized in vitamin K antagonists and vascular calcification research.

Mid-2018 – In collaboration with several academic institutions, LSB MedTech established its own CRO laboratory. This facility provided specialized CRO services to pharmaceutical companies and the food industry, contributing to both clinical and applied research within these sectors.

Mid-2021 – LSB MedTech expanded its activities to include innovation consultancy services in the field of patient care for nursing homes and hospitals. This initiative aimed at developing and implementing innovative healthcare solutions with the primary goal of enhancing patients’ quality of life.

Mid-2023 – The CRO laboratory activities were acquired by a Japanese CRO company, after which LSB MedTech fully transitioned its focus to medical innovation technology, patient care technology, innovation consultancy, and IP valorization. These operations are conducted from the company’s headquarters in the United Arab Emirates and partially in the Netherlands.